Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Research To Practice | Oncology Videos · May 25, 2025 · 48m

Featuring an interview with Dr Lindsey Roeker, including the following topics:

Clinical development of novel Bruton tyrosine kinase (BTK) degraders in therapy for chronic lymphocytic leukemia (CLL) (0:00)

Safety of BTK inhibitors in older and frail patients with CLL (3:41)

Utility of minimal residual disease-guided treatment with venetoclax/obinutuzumab (9:20)

Impact of the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab in CLL (16:32)

Utility of acalabrutinib, venetoclax and obinutuzumab for high-risk CLL (23:31)

Emerging data with sonrotoclax and zanubrutinib in…